Innovative Advances in Alcohol Use Disorder Therapeutics Report 2024: In-depth Insights on 30+ Companies and 30+ Pipeline Drugs [Yahoo! Finance]
MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver [Yahoo! Finance]
MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver